Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT06745479

Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study

Sponsor: Rutgers, The State University of New Jersey

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if attention and ways of thinking impact decision-making and brain processes related to decision-making in people with schizophrenia or schizoaffective disorder relative to people without either condition. It will also learn how brain functioning during decision-making relates to real-world decisions made during daily life. The main questions it aims to answer are: * Does paying attention to specific information impact decision-making and brain processes? * Does thinking in a certain way according to specific 'thinking strategies' improve brain processes related to decision-making? * Does brain functioning during decision-making relate to real-world choices to engage in activities? Researchers will compare brain functioning and decision-making on computer tasks of gambling after participants have been trained to use a positive thinking strategy. They will compare what is different in the brain and behavior when participants use this strategy and when they do not. Participants will also answer brief surveys about activities and feelings for a week in their daily lives. Participants will: * Complete several hours of clinical interviewing, cognitive tests, and surveys of about symptoms, experiences, and personality * Complete computer tasks about gambling decisions during MRI brain scanning and while having their visual attention measured using eye-tracking * Complete brief surveys about their activities and feelings 5 times a day for 1 week using a cell phone. Each survey only take several minutes.

Official title: Promoting Adaptive Decision-Making in Schizophrenia Through Improved Evidence Integration: A Combined Neuroimaging and Experience Sampling Study

Key Details

Gender

All

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

Start Date

2025-01-07

Completion Date

2027-06-30

Last Updated

2026-03-11

Healthy Volunteers

Yes

Conditions

Schizophrenia Schizoaffective Disorder Control Subjects

Interventions

BEHAVIORAL

Positive Emotion Upregulation

Participants will identify personal goals or activities that they would like to engage in more and describe these goals/activities in a written format with research staff. Participants will then complete a gambling task during functional MRI scanning. Prior to making some gambling decisions, participants are instructed to mentally imagine achieving a goal or engaging in an enjoyable activity. Prior to the other decisions participants are instructed to respond naturally (i.e., not use the cognitive strategy).

Inclusion Criteria The following criteria apply to all subjects: 1. Between ages of 18-50. 2. Have capacity to provide informed consent 3. Fluent communication in English 4. Willingness and ability to follow study requirements, as evidenced by an ability to provide written or virtual informed consent and read, and complete, study procedures. 5. Cognitive ability to understand tasks and estimated IQ greater than 70. The following criteria apply to subjects with schizophrenia: 1\. Primary diagnosis of schizophrenia or schizoaffective disorder The following additional criteria apply to subjects without schizophrenia: 1\. Inclusion based on subject matched to psychiatric group based on age, sex, race/ethnicity, and education level. Exclusion Criteria The following criteria apply to all subjects: 1. Self-disclosed or noticeable intoxication from alcohol or illicit drugs (e.g., arriving to participate in the study drunk/high) 2. Self-disclosure of consistent current substance use other than nicotine, alcohol, or cannabis (e.g. cocaine, heroin). 3. Many-year history of severely disordered substance use other than nicotine/tobacco (determined via interview) 4. Significant physical health disorder, robust physical health conditions, neurological disease/disorder (e.g., Parkinson's, history of strokes). 5. History of traumatic brain injury, head injury resulting in loss of consciousness for an extended duration or with noted neurobehavioral consequences. 6. Electroconvulsive therapy within one month of participation. 7. History of seizures or epilepsy. 8. Currently untreated or unstable psychiatric and medical conditions. 9. Intellectual disability 10. Contra indications for MR imaging (detailed below) The following additional criteria apply to subjects without schizophrenia: 1. Pervasive history of problematic substance use (other than nicotine, alcohol, and mild-moderate cannabis use) as defined by meeting DSM-5 criteria for a substance use disorder. 2. Diagnosis of, or first-degree relative with, significant psychiatric disorder (e.g., bipolar disorder, psychotic disorder, or Cluster A personality disorder).

Locations (1)

Center for Advanced Human Brain Imaging Research

Piscataway, New Jersey, United States